You searched for: Antibodies
Explore our premier selection of antibodies designed to advance scientific discovery in diverse laboratory settings. Our comprehensive catalog features monoclonal, polyclonal, and recombinant antibodies, each meticulously verified for applications such as Western Blot, ELISA, ImmunoChemistry, and Flow Cytometry. Tailor your choice by antigen symbol and name, reactivity, clonality, conjugation, and host species to perfectly match your research needs. Enhance your experimental outcomes with our precision-engineered antibodies, optimized for accuracy and reliability.
Human IgG Isotype Control (Unconjugated)
Supplier: Biorbyt
Human IgG Isotype Control
Expand 2 Items
Mouse IgG2a Isotype Control (Unconjugated)
Supplier: Biorbyt
Mouse IgG2a Isotype Control
Expand 1 Items
Mouse IgG2b Isotype Control (Unconjugated)
Supplier: Biorbyt
Mouse IgG2b Isotype Control
Expand 1 Items
Rat IgG Isotype Control (Unconjugated)
Supplier: Biorbyt
Rat IgG Isotype Control (Unconjugated)
Expand 1 Items
Rabbit IgG Isotype Control (Unconjugated)
Supplier: Biorbyt
Rabbit IgG Isotype Control (Unconjugated)
Expand 1 Items
Anti-IFITM3 Mouse Monoclonal Antibody [clone: 2E8D12]
Supplier: MARKET SOURCE PART PROCESS
IFITM3, also named as interferon-inducible protein 1-8U, belongs to the CD225 family. It is IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus, by inhibiting the early steps of replication. IFITM3 is identified as interferon-induced cellular proteins that restrict infections by retroviruses and filoviruses and of influenza virus and flaviviruses, respectively. IFITM3, the most potent antiviral IFITM, was found to inhibit an uncharacterised early infectious event after VSV endocytosis, but before primary transcription of its viral genome. IFITM proteins are viral restriction factors that can inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. They differentially restrict the entry of a broad range of enveloped viruses, and modulate cellular tropism independently of viral receptor expression. This antibody recognises both IFITM2 and IFITM3.